Cilostazol
- Product NDC
- 68151-4123
- 11-digit product format
- 681514123
- Labeler code
- 68151
- Product ID
- 68151-4123_183af410-0b3f-430e-b955-334a9472db6d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cilostazol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Carilion Materials Management
- Application
- ANDA077024
- Marketing category
- ANDA
- Marketing start
- 2005-05-17
- Marketing end
- 0000-00-00
- Substance
- CILOSTAZOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c114def4-591e-cde9-1a9f-29af28d4c1ea | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68151-4123-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4c4b-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use CILOSTAZOL TABLETS safely and effectively. See full prescribing information for CILOSTAZOL TABLETS. CILOSTAZOL tablets, for oral use Initial U.S. Approval: 1999 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68151-4123-2 | Cilostazol | 1 in 1 PACKAGE | TABLET | 1 | 3 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CILOSTAZOL | ACTIVE INGREDIENT | N7Z035406B | CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CILOSTAZOL | ACTIVE MOIETY | N7Z035406B | CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT] | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68151-4123 | CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT] | 3 | Legacy NDC, 1 package rows | 20160806_50fc64ac-7eb3-4bab-8de2-83cd5404d169.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 242461 | cilostazol 100 MG Oral Tablet | PSN | 50fc64ac-7eb3-4bab-8de2-83cd5404d169 | 3 |
| 242461 | cilostazol 100 MG Oral Tablet | SCD | 50fc64ac-7eb3-4bab-8de2-83cd5404d169 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 68151-4123-2 | 68151412302 | 1 in 1 PACKAGE | Historical |